CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 86 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,478,823 | 26.92% |
| Finepoint Capital LP | 539,445 | $13,157,064 | 5.03% |
| Perceptive Advisors | 6,511,727 | $158,851,021 | 4.69% |
| Paradigm Biocapital Advisors LP | 1,595,199 | $38,906,904 | 3.69% |
| BOONE CAPITAL MANAGEMENT LLC | 300,000 | $7,317,000 | 3.42% |
| Affinity Asset Advisors, LLC | 380,000 | $9,268,200 | 3.06% |
| Artal Group S.A. | 1,914,466 | $46,694 | 2.78% |
| Rock Springs Capital Management LP | 2,513,916 | $61,314,411 | 1.46% |
| Frazier Life Sciences Management, L.P. | 393,000 | $9,585,270 | 0.69% |
| Hood River Capital Management LLC | 572,876 | $13,972,000 | 0.45% |